'Ldl lowering' presentation slideshows

CHOLESTEROL AND OUR LIVES ???????? ???????

CHOLESTEROL AND OUR LIVES ???????? ???????. OMAR DHAIMAT,MD FACE Dr. Sulaiman Al- Habib medical Center. CHOLESTEROL ????????. QUANTITY AND QUALITY. RISK FACTORS FOR HEART DISEASE. HEART AND VESSELS. Adult Treatment Panel III (ATP III) Guidelines.

797 views • 69 slides

Craig Williams, Pharm.D ., FNLA Associate Professor; OSU School of Pharmacy and OHSU School of Medicine williacr@ohsu.e

Craig Williams, Pharm.D ., FNLA Associate Professor; OSU School of Pharmacy and OHSU School of Medicine williacr@ohsu.edu. 2011 Annual Diabetes Practice Update Session: Update on Cardiovascular Disease & Diabetes: Prevention of CVD in Patients with Diabetes September 30 th , 2011.

1.07k views • 60 slides

803 views • 60 slides

Risk in the wake of ATP III

524 views • 52 slides

322 views • 32 slides

Step 3

Step 3. P-treatment: Drug Class Selection. Pharmacological and Non-Pharmacological Management. Drug Classes. MOA HMG- CoA reductase inhibitor : reduces hepatic cholesterol synthesis Efficacy (++++) Significant reduction of LDL (up to 35%) Increase in HDL (5-10 %)

302 views • 21 slides

Implications of Recent Clinical Trials for the NCEP ATP III Guidelines

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

402 views • 16 slides